Cargando…
Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion
INTRODUCTION: Haycocknema perplexum is an exceedingly rare cause of parasitic myositis endemic to Australia, more specifically, Tasmania and North Queensland. There is a paucity of literature regarding this diagnosis, with only nine previously described cases. DIAGNOSIS: This report details two case...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119132/ https://www.ncbi.nlm.nih.gov/pubmed/35663589 http://dx.doi.org/10.1136/bmjno-2022-000290 |
_version_ | 1784710641967169536 |
---|---|
author | Ward, Kayla Krishnan, Anirudh R Iyengar, Krishnan Robertson, Thomas White, Richard Urkude, Ravindra |
author_facet | Ward, Kayla Krishnan, Anirudh R Iyengar, Krishnan Robertson, Thomas White, Richard Urkude, Ravindra |
author_sort | Ward, Kayla |
collection | PubMed |
description | INTRODUCTION: Haycocknema perplexum is an exceedingly rare cause of parasitic myositis endemic to Australia, more specifically, Tasmania and North Queensland. There is a paucity of literature regarding this diagnosis, with only nine previously described cases. DIAGNOSIS: This report details two cases of biopsy-confirmed H. perplexum myositis from Townsville University Hospital and describes the first-ever case of subclinical infection. There is limited known information regarding the H. perplexum life cycle and a definitive host which has hindered the development of a non-invasive diagnostic test. A review of the previously described cases has identified the hallmark features of this enigmatic condition: a triad of serological markers including deranged hepatic function, persistent eosinophilia and an elevated creatine kinase. CONCLUSIONS: This report aimed to raise awareness of H. perplexum myositis and the possibility of subclinical infection, which suggests a protracted disease course. Further research is required to identify a non-invasive diagnostic test, given that early diagnosis and timely initiation of albendazole treatment may drastically limit patient disability. |
format | Online Article Text |
id | pubmed-9119132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-91191322022-06-04 Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion Ward, Kayla Krishnan, Anirudh R Iyengar, Krishnan Robertson, Thomas White, Richard Urkude, Ravindra BMJ Neurol Open Short Report INTRODUCTION: Haycocknema perplexum is an exceedingly rare cause of parasitic myositis endemic to Australia, more specifically, Tasmania and North Queensland. There is a paucity of literature regarding this diagnosis, with only nine previously described cases. DIAGNOSIS: This report details two cases of biopsy-confirmed H. perplexum myositis from Townsville University Hospital and describes the first-ever case of subclinical infection. There is limited known information regarding the H. perplexum life cycle and a definitive host which has hindered the development of a non-invasive diagnostic test. A review of the previously described cases has identified the hallmark features of this enigmatic condition: a triad of serological markers including deranged hepatic function, persistent eosinophilia and an elevated creatine kinase. CONCLUSIONS: This report aimed to raise awareness of H. perplexum myositis and the possibility of subclinical infection, which suggests a protracted disease course. Further research is required to identify a non-invasive diagnostic test, given that early diagnosis and timely initiation of albendazole treatment may drastically limit patient disability. BMJ Publishing Group 2022-05-18 /pmc/articles/PMC9119132/ /pubmed/35663589 http://dx.doi.org/10.1136/bmjno-2022-000290 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Short Report Ward, Kayla Krishnan, Anirudh R Iyengar, Krishnan Robertson, Thomas White, Richard Urkude, Ravindra Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion |
title | Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion |
title_full | Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion |
title_fullStr | Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion |
title_full_unstemmed | Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion |
title_short | Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion |
title_sort | haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119132/ https://www.ncbi.nlm.nih.gov/pubmed/35663589 http://dx.doi.org/10.1136/bmjno-2022-000290 |
work_keys_str_mv | AT wardkayla haycocknemaperplexummyositisthefirstdescriptionofsubclinicaldiseaseandaproposeddistinctivetriadtoevokeclinicalsuspicion AT krishnananirudh haycocknemaperplexummyositisthefirstdescriptionofsubclinicaldiseaseandaproposeddistinctivetriadtoevokeclinicalsuspicion AT riyengarkrishnan haycocknemaperplexummyositisthefirstdescriptionofsubclinicaldiseaseandaproposeddistinctivetriadtoevokeclinicalsuspicion AT robertsonthomas haycocknemaperplexummyositisthefirstdescriptionofsubclinicaldiseaseandaproposeddistinctivetriadtoevokeclinicalsuspicion AT whiterichard haycocknemaperplexummyositisthefirstdescriptionofsubclinicaldiseaseandaproposeddistinctivetriadtoevokeclinicalsuspicion AT urkuderavindra haycocknemaperplexummyositisthefirstdescriptionofsubclinicaldiseaseandaproposeddistinctivetriadtoevokeclinicalsuspicion |